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Abstract
Purpose Informal care constitutes an important part of the total care for people with dementia. Therefore, the impact of the 
syndrome on their caregivers as well as that of health and social care services for people with dementia should be considered. 
This study investigated the convergent and clinical validity of the CarerQol instrument, which measures and values the impact 
of providing informal care, in a multi-country sample of caregivers for people with dementia.
Methods Cross-sectional data from a sample of 451 respondents in eight European countries, collected by the Actifcare 
project, were evaluated. Convergent validity was analysed with Spearman’s correlation coefficients and multivariate cor-
relations between the CarerQol-7D utility score and dimension scores, and other similar quality of life measures such as 
CarerQol-VAS, ICECAP-O, and EQ-5D. Clinical validity was evaluated by bivariate and multivariate analyses of the degree 
to which the CarerQol instrument can differentiate between characteristics of caregivers, care receivers and caregiving situ-
ation. Country dummies were added to test CarerQol score differences between countries.
Results The mean CarerQol utility score was 77.6 and varied across countries from 74.3 (Italy) to 82.3 (Norway). The scores 
showed moderate to strong positive correlations with the CarerQol-VAS, ICECAP-O, and EQ-5D health problems score of the 
caregiver. Multivariate regression analysis showed that various characteristics of the caregiver, care receiver and caregiving 
situation were associated with caregiver outcomes, but there was no evidence of a country-level effect.
Conclusion This study demonstrates the convergent and clinical validity of the CarerQol instrument to evaluate the impact 
of providing informal care for people with dementia.
Keywords Construct validity · CarerQol instrument · Informal care · Dementia
Introduction
In 2019, the number of people with dementia was estimated 
at 50 million worldwide, and every 3 s a new case of demen-
tia occurred [1–3]. The number of people with dementia 
therefore is increasing rapidly and will most likely more 
than triple by 2050 [3, 4]. Furthermore, dementia has a huge 
economic impact. The worldwide care costs of dementia in 
2015 were estimated to be 818 billion dollars [1]. With no 
cure that can alter the course of this disorder or modifying 
treatment currently available, it is crucial that a caregiving 
context is created in which people with dementia are sup-
ported in their care needs.
Dementia is a chronic syndrome that progresses over time 
with corresponding increasing care demands [5, 6]. Most of 
this care is placed on the shoulders of family members of the 
person with dementia [7]. It was estimated that informal care 
has a three-to-one ratio with formal care in care provided/
received [6, 8].
Informal care for people with dementia plays a crucial role 
in the total care for people with dementia and is relatively time 
intensive [5, 9, 10]. Without sufficient help, providing infor-
mal care to someone with dementia can turn into a full-time 
job [11] with significant influence on the well-being of the 
caregiver [12]. On the one hand, caring can be very gratifying 
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and caregivers may experience positive utility from providing 
care [13, 14], but on the other hand, it can also be experienced 
as burdensome and overwhelming [15], potentially leading to 
physical, emotional and economic strain [3, 12]. Because the 
role of informal caregivers can be expected to remain indis-
pensable in the foreseeable future, interventions aimed at sup-
porting and strengthening caregivers of people with dementia 
are extremely important [5].
Most health care systems struggle with accommodating the 
rising demand for health and social care from a limited budget. 
Economic evaluation studies are increasingly used to inform 
decision-makers about which interventions to fund and not 
to fund [16]. Informal care can have a strong impact on the 
outcomes of these economic evaluations, but it is usually not 
considered [17]. In addition, studies that do consider informal 
care mostly focus on the costs of caregiving (the numerator 
in the cost-effectiveness ratio), which constitutes only partial 
information on the overall effects of providing care on infor-
mal caregivers. For a fair consideration of the full impact on 
caregivers in economic evaluation studies, it is important to 
assess the effect of providing informal care on the well-being 
of caregivers (the denominator in the cost-effectiveness ratio). 
The CarerQol (Care-Related Quality of Life) instrument was 
developed for this purpose [18].
The CarerQol instrument can be used in economic evalua-
tions for two purposes. First, as primary outcome measure in 
evaluations of interventions aimed at informal caregivers. Sec-
ondly, as additional information in evaluations of health and 
social care interventions for people with dementia. Since its 
introduction in 2006 [18], the CarerQol has been validated in 
different populations and caregiving contexts such as family of 
caregivers of children with craniofacial malformations, parents 
of adults with Duchenne muscular dystrophy, caregivers of a 
child with autism spectrum disorder and caregiver outcomes 
in palliative care [19–25]. Until now, the CarerQol has been 
used once in a population of informal caregivers for people 
with dementia [26]; however, it has never been validated in 
this population. Considering that the validity of an instrument 
may differ between settings, it is important that the CarerQol 
is also validated in the context of dementia. The aim of this 
paper was to investigate the convergent and clinical validity of 
the CarerQol in the context of informal caregivers for people 
with dementia, using cross-sectional baseline data from eight 
European countries collected within the Actifcare (Access to 
TImely Formal care) project [27].
Methods
Study design and participants
Data were obtained within the Actifcare study, which is a 
prospective longitudinal cohort study. People with dementia 
and their informal caregivers were recruited in eight Euro-
pean countries (Germany, Ireland, Italy, the Netherlands, 
Norway, Portugal, Sweden and the UK (United Kingdom)) 
in 2014 and 2015. The study sample consisted of 451 pairs 
of carers and care recipients, of which 18 (4.0%) were 
excluded because they had missing values on at least one 
of the seven dimensions of the CarerQol. The remaining 
433 pairs of carers and care recipients were distributed over 
the eight countries as follows: Germany (45; 10.4%), Ire-
land (41; 9.5%), United Kingdom (74; 17.1%), Sweden (50; 
11.6%), Norway (58; 13.4%), Italy (51; 11.8%), Portugal 
(66; 15.2%) and The Netherlands (48; 11.1%).
The data were collected through interviews and question-
naires [28]. The person with dementia and his/her primary 
informal caregiver were interviewed by a trained interviewer 
about their socio-demographic characteristics, comorbidities 
and the health care resource usage of the care receiver. After 
this, the person with dementia was interviewed about his/
her care needs, health and quality of life, while the caregiver 
completed a questionnaire covering a variety of outcome 
measures. Lastly, the caregiver was interviewed about the 
caregiving situation and the health of the care receiver in 
order to evaluate his/her needs for formal care. The infor-
mal caregiver could be a spouse, partner, child, other family 
member or a friend.
Inclusion criteria of the Actifcare study for care receivers 
included a clinical diagnosis of dementia, and not receiv-
ing regular paid personal care because of their demen-
tia. Additional eligibility criteria included CDR (Clinical 
Dementia Rating) 1 or 2, or a MMSE (Mini-Mental State 
Examination) score of less than 25; a professional judge-
ment that additional assistance with personal care is likely 
to be needed within 1 year; no terminal condition or comor-
bidities; no care home or nursing home residency within the 
last 6 months (see online Appendix 1 for full inclusion and 
exclusion criteria details).
Demographic characteristics of people with dementia and 
their caregivers included age, gender, level of education, 
marital status, occupation, living situation, whether car-
egiver and care receiver live together, and contact frequency 
between caregiver and care receiver.
Measures for informal caregivers
Quality of life measures such as the CarerQol, ICECAP-O 
(ICEpop CAPability measure for Older people), EQ-5D-5L 
(EuroQol-5D-L) and PT (Perseverance Time) were com-
pleted by the caregivers.
The CarerQol combines a multi-dimensional measure 
of the impact of the caregiving situation (CarerQol-7D) 
with a valuation component in terms of well-being (Car-
erQol Visual Analogue Scale (CarerQol-VAS)) [18]. The 
CarerQol-7D consists of five negative and two positive 
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dimensions of providing informal care. The negative 
dimensions are relational problems, mental health prob-
lems, problems combining daily activities with care, finan-
cial problems and physical health problems because of 
providing informal care. The two positive dimensions are 
fulfilment from caregiving and support with lending care. 
For each dimension, there are three possible responses: no, 
some and a lot. The CarerQol-VAS is a visual analogue 
scale that ranges from 0 (completely unhappy) to 10 (com-
pletely happy) on which caregivers can indicate how happy 
they felt [18]. The CarerQol is currently available in the 
following languages: English, Dutch, German, Norwegian, 
Swedish, Italian, Spanish and Portuguese. German, Nor-
wegian, Swedish, Italian, Spanish and Portuguese transla-
tions of the CarerQol are made available by ACTIFcare 
[27]. The English translation, as described by Hoefman 
et al.: “was performed by the authors and checked for 
accuracy by native speakers and informal care researchers 
from Australia, UK and US [29]”. Afterwards, the original 
English version of the CarerQol instrument [18] was trans-
lated into other languages using forward–backward trans-
lation and pilot-tested following a translation protocol [28, 
30]. Utility tariffs for the CarerQol have been developed to 
calculate a CarerQol-7D utility score from the responses 
on the seven dimensions, ranging between 0 (‘worst imagi-
nable caregiving situation’) and 100 (‘best imaginable car-
egiving situation’), for which discrete choice experiments 
were used [25, 29, 31]. Higher utility scores thus reflect 
better care-related quality of life. The worst informal care 
situation concerns one with a lot of problems on all five 
negative dimensions of providing informal care, and no 
support or fulfilment, while the best informal care situ-
ation is characterized by no problems on any of the five 
negative dimensions and a lot of support and fulfilment 
from caregiving.
The ICECAP-O is a measure of well-being and capabil-
ity in the older population and comprises of five attributes: 
attachment, security, role, enjoyment and control, with one 
question per dimension, each scored on four levels [32]. A 
tariff for the UK is available to compute a composite score 
on a scale from 0 (‘no capability’) to 1 (‘full capability’) 
[33]. The ICECAP-O has been validated within the Actifcare 
project and appeared to be a valid measure of well-being in 
informal caregivers for people with dementia [34].
The EQ-5D is an instrument on which respondents can 
describe their health on five dimensions of health-related 
quality of life (mobility, self-care, usual activities, pain/dis-
comfort and anxiety/depression), each scored on five levels, 
and a VAS rating scale ranging between 0 (‘worst imagina-
ble health state’) and 100 (‘best imaginable health state’) 
[35]. The level scores on the five dimensions were added up 
to determine an EQ-5D health problems score ranging from 
0 to 20, with higher scores indicating more health problems.
Because value sets for the CarerQol-7D (only available 
for the Netherlands [31], Germany, Sweden and UK [29]) 
and ICECAP-O are not available for all eight countries 
included in this study, we used UK value sets for both 
instruments [29, 36] to calculate utility scores. Because 
the UK value set for the EQ-5D-5L version has been sub-
ject of debate [37], only the EQ-5D health problems score 
is used.
Finally, PT was used, which is an instrument that asks 
caregivers to estimate how long they can continue to pro-
vide care to the person with dementia, if the caregiving 
situation remains stable [26]. It offers six answer catego-
ries: less than 1 week, more than 1 week but less than 
1 month, more than 1 month but less than 6 months, more 
than 6 months but less than 1 year, more than a year but 
less than 2 years, and more than 2 years.
Measures for people with dementia
The quality of life, dementia severity and various domains 
of symptoms were measured by the following instruments: 
EQ-5D, CDR, MMSE, Neuropsychiatric Inventory (NPI-
Q), Lawton instrumental activities of daily living scale 
(IADLS), Physical Self-Maintenance Scale (PSMS) and 
Camberwell Assessment of Need for the Elderly (CANE) 
of care receivers were used [28].
CDR reflects the care receiver’s dementia severity. It has 
the ability to distinguish from healthy to severely impaired 
[38]. The interviewer evaluated the cognitive and functional 
abilities of the person with dementia in six different dimen-
sions: memory, orientation, judgement and problem solving, 
community affairs, home and hobbies, and personal care. 
The scores on all the dimensions can be combined into a 
composite score ranging from 0 (no dementia) to 3 (severe 
dementia) [38], and categorized into ‘mild’ (CDR = 1) or 
‘moderate or severe’ (CDR > 1).
MMSE reflects cognitive functioning [39], the NPI-Q 
neuropsychiatric symptoms [40], and the IADLS and PSMS 
were used to rate instrumental and basic activities of daily 
living, respectively [41].
The CANE measures the needs of older people with men-
tal disorders [42]. Here, the rater perspective was used for 
all 24 domains of need of people with dementia. The total 
score represents the total of unmet needs [42].
Lastly, the RUD (Resource Use in Dementia) measure 
was completed by caregivers and evaluates the use of social 
services, frequency and duration of hospitalizations, con-
tacts with health care professionals, use of concomitant med-
ications by both the caregiver and the person with dementia, 
amount of time the caregiver spends caring for the person 
with dementia, and productivity losses [43].
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Validity
Similar to previous studies [18, 23, 24], we adopted the 
definition of convergent validity as the degree to which two 
measures of constructs that theoretically should be related 
are in fact related. In this study, the relation between the 
CarerQol and the CarerQol-VAS, PT, ICECAP-O and 
EQ-5D was examined. The clinical validity was evaluated 
as the degree to which CarerQol utility scores distinguished 
between subgroups defined by characteristics of caregivers, 
care receivers and the caregiving situation as expected [18].
Statistical analysis
Descriptive statistics of all variables were calculated using 
either frequencies and proportions or means and standard 
deviations.
Convergent validity was evaluated using Spearman cor-
relation coefficients. We expected the CarerQol-7D utility 
score to have a strong positive correlation with the well-
being measures CarerQol-VAS and ICECAP-O, a moderate 
positive correlation with PT, and a moderate negative corre-
lation with the EQ-5D health problems score. We also antici-
pated the two positive dimensions to have moderate positive 
correlations with CarerQol-VAS, ICECAP-O and PT, and 
moderate negative correlation with the EQ-5D health prob-
lems score; opposite correlations were expected for the five 
negative dimensions of the CarerQol-7D.
Clinical validity was analysed by bivariate and multi-
variate analyses. First, differences in mean CarerQol util-
ity values for subgroups defined by different characteris-
tics of caregivers, care receivers and caregiving situations 
were inspected. Next, multivariate regression models were 
estimated using all characteristics that were significant at 
p < 0.20 in the bivariate analyses. Continuous variables were 
tested by means of squared terms to explore whether the 
relationship was non-linear. Finally, the effect of country 
was tested by adding a set of dummies, reflecting all the 
countries, to the multivariate model. Given the lack of evi-
dence, we hypothesized no differences in CarerQol scores 
between countries.
Cohen’s Set Correlation and Contingency Tables were 
used to differentiate between strong (above 0.5), moderate 
(between 0.3 and 0.5) and weak (below 0.3) correlations 
[44].
Analyses were performed using Stata 16.0 [45].
Results
The characteristics of our study sample are shown in 
Table 1. Caregivers had an average age of 66 years and 
were predominantly female (66%). They had an average 
of 12 years of education, 28% was employed and 63% 
was retired. The caregivers rated their health and well-
being on average as reasonably good, with an EQ-5D 
health problems score of 7.9, an EQ-VAS score of 72, and 
an ICECAP-O score of 0.78. On average, care receivers 
were almost 12 years older than caregivers and 55% of 
care receivers were female. The average number of years 
of education was nearly 10, and almost all were retired 
(93%). Care receivers had an EQ-5D health problems score 
of 7.9, which was similar to the score of caregivers. For 
one out of five of the care receivers, their dementia was 
rated as ‘moderate or severe dementia’ (CDR > 1). Most 
care receivers had low to moderate problems with their 
mental health and were dependent on help because of their 
physical health. Less than 5% of care receivers stayed in 
a hospital during the past 30 days, 72% saw a healthcare 
professional at home once or more often, and 26% reported 
one or more home care visits by a healthcare professional. 
About 35% had no unmet care needs, a similar proportion 
had one or two unmet needs, and 28% had three or more 
unmet care needs.
The majority of caregivers (63%) provided informal 
care to their spouse or partner, and 71% shared a household 
with the care receiver. Mean caregiving time over the past 
30 days was 6.0 h per day (95% confidence interval: 5.4 to 
6.5 h), with about 29% providing 8 h of care per day or more. 
Approximately 13% of the caregiving time was spent on 
assisting with basic activities of daily living, 45% on assist-
ing with instrumental activities of daily living, and 42% on 
supervising the person with dementia.
Regarding PT, 71% of caregivers indicated they would be 
able to carry on with their caregiving activities for at least 2 
years if the care situation remained the same.
CarerQol scores
Figure 1 shows the distribution of the seven dimensions of 
the CarerQol-7D across countries. Almost all caregivers 
experienced at least some fulfilment from caregiving and 
three out of four received at least some support with carrying 
out their care tasks when needed. Comparable proportions 
of approximately 60% of caregivers reported some or a lot 
of problems with their own mental or physical health, in 
their relationship with the care receiver, or combining care 
tasks with their daily activities. The large majority reported 
to have no financial problems, but 5% of caregivers had a lot 
of financial problems due to caregiving.
The mean CarerQol-7D utility score derived from these 
dimension scores was 77.6 (SD 17.4), with a 95% confidence 
interval of 75.9 to 79.2. Norway had the highest (82.3) and 
Italy the lowest (74.3) mean score (see Table 2). The aver-
age CarerQol-VAS score (or happiness) was 6.4 (SD 1.93).
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Table 1  Characteristics of 
caregivers, care receivers and 
caregiving situations (n = 433), 
and bivariate correlation with 
CarerQol-7D utility score





Low (< 66 years) 43.0% 76.7 0.33
High (≥ 66 years) 57.0% 78.4
Gender Male 34.0% 79.4 0.14
Female 66.0% 76.8
Years of education 11.9 (4.5)
Low (< 13 years) 56.3% 76.9 0.32
High (≥ 13 years) 43.7% 78.6
Occupation Employed 28.5% 79.7 0.12
Other 71.5% 76.8
EQ-5D health problems score 7.9 (2.9)
Low (≤ 6) 38.3% 85.3  < 0.01
Middle (> 6 & < 12) 50.4% 75.3





Low (< 78 years) 78.1% 77.4 0.65
High (≥ 78 years) 21.9% 78.4
Gender Male 44.8% 75.0  < 0.01
Female 55.2% 79.8
Years of education 9.8 (4.5)
Low (< 13 years) 75.5% 77.8 0.68
High (≥ 13 years) 24.5% 77.0
Occupation Retired 92.6% 77.9 0.21
Other 7.4% 73.9
EQ-5D health problems score 7.9 (2.9)
Low (≤ 6) 39.3% 78.3 0.12
Middle (> 6 & < 12) 46.4% 78.4
High (≥ 12) 14.3% 73.5
CDR Mild (= 1) 79.2% 78.8  < 0.01
Moderate or severe (> 1) 20.8% 73.3
MMSE 19.0 (5.0)
Mild (> 20) 38.3% 78.3 0.13
Moderate (10–20) 57.2% 77.9
Severe (< 10) 4.5% 69.2
NPI-Q 7.8 (5.5)
Low (0–7) 54.1% 82.0  < 0.01
High (8–30) 45.9% 72.9
IADLS 3.4 (2.0)
Independent (5–8) 26.7% 82.9  < 0.01
Dependent (≤ 4) 73.3% 75.9
PSMS 3.6 (1.9)
Independent (4–8) 42.4% 81.4  < 0.01
Dependent (0–4) 57.6% 74.9
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Convergent validity
Table 3 shows the Spearman’s correlation coefficients of 
the CarerQol-7D utility and dimension scores with other 
measures of quality of life such as the CarerQol-VAS, ICE-
CAP-O utility score, and EQ-5D health problems score of 
the caregiver. The CarerQol-7D utility score was positively 
correlated with CarerQol-VAS (moderate; 0.475) and ICE-
CAP-O utility (strong; 0.530), and negatively with EQ-5D 
health problems score (moderate; −0.437). A weak correla-
tion was found between the CarerQol-7D utility score and 
PT (0.290). The correlations of the CarerQol-7D dimensions 
with these same instruments all had the expected direction, 
were generally weak or moderate, but not always statistically 
significant. Overall the correlations with the ICECAP-O util-
ity score were the strongest, but the fulfilment dimension 
showed highest correlation with CarerQol-VAS and the 
physical health dimension showed highest correlation with 
the EQ-5D health problems score.
Clinical validity
Bivariate analyses (see Table 1) showed that the CarerQol-
7D utility score was associated with a number of charac-
teristics of the caregiver, care receiver and care situation; 
in particular, indicators of poorer health of the caregiver 
and care receiver generally were associated with a lower 
CarerQol utility score, as were providing care to a male 
care recipient and providing more caregiving hours.
Table 4 presents the results of the multivariate analy-
ses, in which all the variables that were significant on a 
p < 0.20 level in the bivariate analyses (plus caregivers’ 
age and years of education, and care recipients’ age) were 
considered. The age and health of the caregiver, the CDR, 
visits to health care professionals and unmet care needs of 
the care receiver, and the number of caregiving hours were 
the most important explanatory variables for CarerQol-7D 
utility scores. None of the squared terms for continuous 
Table 1  (continued) Variable Mean (SD) or % CarerQol-7D util-
ity score
Mean p-value
Hospital days (RUD) 0.20 (1.7)
None 96.5% 77.7 0.36




None 27.6% 79.4  < 0.01
One 38.8% 79.5
Two or more 33.6% 73.9
Home care visits (RUD) 9.1 (39.3)
None 74.4% 77.6 0.85
One or more 25.6% 77.3
Unmet care needs (CANE) 1.8 (2.0)
None (0) 35.6% 80.6  < 0.01
Low (1 or 2) 36.2% 78. 0








No 28.6% 80.4 0.03
Yes 71.4% 76.5
Caregiving time in hours
per day (RUD)
6.0 (5.6)
 ≤ 1 h 22.5% 82.4  < 0.01
 > 1 & ≤ 4 h 29.1% 77.0
 > 4 & ≤ 8 h 19.8% 77.2
 > 8 h 28.6% 73.0
CarerQol-7D Care-related Quality of Life instrument-7D, SD standard deviation, EQ-5D EuroQol-5D, 
CDR clinical dementia rating, MMSE mini-mental state examination, NPI-Q neuropsychiatric inventory, 
IADLS Lawton Instrumental Activities of Daily Living Scale, PSMS Physical Self-Maintenance Scale, 
RUD resource use in dementia, CANE Camberwell assessment of need for the elderly
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variables were statistically significant (p < 0.05), indicat-
ing that relationships were approximately linear. 
Although mean CarerQol-7D utility scores varied con-
siderably between countries (see Table 2), they were not 
significant (p < 0.05) when added to the model presented in 
Table 4 as a set of dummy variables.
Discussion
This study investigated the convergent and clinical valid-
ity of the CarerQol instrument as measure of the impact 
of caregiving for people with dementia on informal car-
egivers, using rich data from a multi-country sample. The 
Fig. 1  Distribution of the CarerQol-7D dimension scores across countries (in percentages) DE, Germany; IE, Ireland; IT, Italy; NL, the Nether-
lands; NO, Norway; PT, Portugal, SE, Sweden; UK, the United Kingdom
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correlations between the CarerQol-7D utility score and the 
CarerQol-VAS, PT, ICECAP-O utility score and EQ-5D 
health problems score of the caregiver had the expected 
direction and were statistically significant, but for some a 
lower strength was found compared to what was expected. 
Previous research using these data found a strong and posi-
tive correlation between the CarerQol-7D and the ICECAP-
O [34], a measure of overall capability well-being; in this 
study we report the same coefficient (0.53). As expected, 
the positive (negative) dimensions of the CarerQol-7D were 
positively (negatively) correlated with the CarerQol-VAS, 
although some only weakly. These findings generally sup-
port the convergent validity of the CarerQol instrument in 
this sample. In addition, the CarerQol instrument was able 
to distinguish between subgroups defined by a number of 
relevant characteristics of caregivers, care receivers and the 
caregiving situation in the expected directions, more spe-
cifically, the age and health of caregivers, the CDR, visits 
to healthcare professionals and unmet care needs of care 
receivers, and caregiving time. This generally supports the 
clinical validity of the CarerQol instrument. We also hypoth-
esized that there would be no significant differences in Car-
erQol scores between the participating countries, as there 
was no previous evidence suggesting this. Although the 
observed mean CarerQol-7D utility scores differed consid-
erably between countries (Table 2), the multivariate analyses 
showed that these differences were most likely related to 
differences in the composition of the samples between the 
countries and reflect differences in healthcare systems. This 
confirms our hypothesis.
The convergent and validity results of this study among 
caregivers for people with dementia are generally in line 
with findings from previous CarerQol validation studies in 
other settings [18, 23, 24]. Although most of these studies 
focused on the CarerQol-VAS and CarerQol-7D dimensions 
instead of the CarerQol-7D utility score, as utility tariffs 
were not yet available when these studies were conducted, 
the results are comparable. Therefore, this study confirms 
that the CarerQol instrument may be a useful instrument to 
assess the impact of caregiving on the well-being of informal 
caregivers for use in economic evaluations of interventions 
for caregivers or care recipients [23].
Some limitations of this study need to be mentioned. 
First of all, UK value sets were used to compute utility 
scores for the CarerQol and the ICECAP-O for all coun-
tries included in the analysis, because at this time country-
specific value sets were not available for these instruments 
for each of the countries included in this study. Using 
the same utility tariffs for all supports the comparability 
across countries; however, this obviously may limit the 
representativeness of these scores in the separate coun-
tries, as the relative value of dimensions and levels may 
differ from those in the UK. It would be helpful if country-
specific value sets for the CarerQol and ICECAP-O were 
developed for more countries. Furthermore, in this study 
Table 2  CarerQol-7D utility score, by country
CarerQol-7D Care-related Quality of Life instrument-7D, 95% CI 
95% confidence interval
Country CarerQol-7D utility score
Mean 95% CI of mean
Italy 74.3 69.7 – 78.9
Ireland 74.7 68.0 – 81.4
Germany 75.5 70.7 – 80.2
The Netherlands 75.8 70.0 – 81.5
United Kingdom 76.1 72.4 – 79.8
Portugal 79.3 74.8 – 83.7
Sweden 81.9 76.9 – 87.0
Norway 82.3 78.8 – 85.8
Total 77.6 76.0 – 79.3
Table 3  Convergent validity (Spearman’s rho; 2-tailed)
*p < 0.05, **p < 0.01, ***p < 0.001, n.s. not significant
CarerQol-7D Care-related Quality of Life instrument-7D, CarerQol-VAS  Care-Related Quality of Life instrument-Visual Analogue Scale, ICE-





CarerQol-7D utility score 0.475 *** 0.530 *** −0.437 ***
CarerQol-7D dimensions Fulfilment 0.340 *** 0.271 *** −0.094 *
Relational problems −0.318 *** −0.332 *** 0.202 ***
Mental health problems −0.396 *** −0.455 *** 0.358 ***
Problems with daily activities −0.232 *** −0.259 *** 0.157 **
Financial problems −0.222 *** −0.309 *** 0.210 ***
Support 0.151 ** 0.134 ** −0.131 *
Physical health problems −0.281 *** −0.389 *** 0.498
***
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we used the capability well-being measure ICECAP-O for 
testing the convergent validity of the CarerQol. Ideally a 
carer-specific measure would have been used; however, at 
the time of development of the protocol of this study no 
alternative measures with utility weights were available. It 
is also important to note that the ICECAP-O was used for 
both people with dementia and their carers, where 43% of 
the caregivers were < 66 years old. However, the ICECAP-
O was initially developed for people 65 years and older 
and it is not completely clear how valid this measure is 
in capturing the well-being of people below this range. 
Although the size of the overall sample is sufficient for 
the intended analyses, the sample sizes per country ranged 
between 41 and 74. This raises questions about the pos-
sibility to conduct country-level sub-group analyses. The 
sample consisted of people with relatively mild demen-
tia and mostly low burden care situations. Although this 
arguably may be the most prevalent caregiving situation 
in the context of informal care for people with dementia 
in the community, this limits the generalizability of our 
findings to the wider population of caregivers for people 
with dementia. In addition, convenience sampling possi-
bly has underrepresented highly burdened caregivers not 
able to participate in this study. Finally, although ques-
tionnaires were carefully back-translated and pilot-tested, 
most of the instruments were not validated in all the dif-
ferent countries. Therefore, our findings may be biased 
by cultural differences in the comprehensiveness of the 
various measures and the way participants interpreted and 
responded to these measures. Future research should focus 
on validating the instruments in all different countries and 
on cross-cultural validation.
One of the strengths of the current study is that, as com-
pared to previous validation studies of the CarerQol instru-
ment, we had a sizeable sample from different countries at 
our disposal. Secondly, the data contained a large variety of 
characteristics of caregivers, care receivers and caregiving 
situations relevant for this specific population. Finally, data 
were gathered on and from both caregiver and care receiver, 
using a detailed protocol and trained interviewers in all par-
ticipating countries, which promoted the comprehensiveness 
and quality of the data available for this study. Nevertheless, 
future studies would benefit from a larger sample size (per 
country) and the availability of country-specific validated 
versions and value sets for the various measures of outcome. 
In addition, panel data would facilitate the investigation of 
causality in the relation between caregiver outcomes and 
characteristics of caregivers, care receivers and the caregiv-
ing situation. This would be important to improve the quality 
of the evidence in this area, which in turn would support the 
consideration of effects of interventions in health and social 
care for people with dementia on their informal caregivers. 
This research has shown that the impact on informal caregiv-
ers is related to the severity of dementia and the size of the 
caregiving task. This finding is relevant for future policy, 
given the current emphasis in many countries on promoting 
people with dementia to live at home longer. The growing 
number of people with dementia worldwide and the limited 
Table 4  Multivariate linear 
regression for CarerQol-7D 
utility score (n = 405)
Coef coefficient, Std. Err. standard error, EQ-5D EuroQol-5D, CDR clinical dementia rating
Variable Coef. Std. Err. p-value
Caregiver
Age 0.33 0.13 0.009
Gender (female) 0.72 2.19 0.745
Years of education 0.12 0.18 0.520
Occupation (employed) 3.60 2.51 0.151
EQ-5D health problems score −2.73 0.27 0.000
Care recipient
Age 0.04 0.14 0.767
Gender (female) 2.28 2.18 0.298
EQ-5D health problems score 0.06 0.27 0.819
CDR (moderate or severe) −5.12 1.88 0.007
Healthcare professional visits (two or more) −4.87 1.58 0.002
Unmet care needs (high) −4.44 1.68 0.009
Caregiving situation
Relationship with care recipient (spouse or partner) 1.04 4.00 0.794
Care recipient lives with caregiver (yes) 0.30 2.86 0.918
Caregiving time (hours per day) −0.38 0.15 0.013
Constant 71.23 12.47 0.000
Adj.  R2 0.27
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availability of informal caregivers emphasize the importance 
of adequate support for informal caregivers to assist them in 
their important caregiving tasks. Our findings suggest that 
special attention should be directed at caregivers of older 
age and who have health problems themselves, and more 
demanding care situations in terms of severity of the health 
problems and unmet care needs of the care receiver, and 
hours of caregiving required.
It is worth noting that there are many measures of car-
egiving effects available, with different properties and scopes 
of measurement and valuation. The CarerQol is a relatively 
short (i.e. seven items) and generic measure, whereas, for 
example, the recently introduced the SIDECAR (Scales 
measuring the Impact of DEmentia on CARers) [46] is a 
fairly elaborate (i.e. 39 items) and dementia-specific meas-
ure. Disease-specific measures generally have the advantage 
of capturing the effects on carers for patients in that par-
ticular population more precisely, while generic measures 
have the advantage that measurement of effects is the same 
and hence comparable across carer and patient populations, 
which facilitates development and evaluation of policies on 
a more general level. In addition, many measures focus only 
on the burden of caregiving, while for many carers there are 
also positive effects—such as the fulfilment item included in 
the CarerQol—that potentially make the overall caregiving 
experience less straining [18]. Finally, measures differ in 
how carers can report their experience (e.g. yes/no, agree/
disagree, or different degrees/levels) and whether and how 
a sum-score is defined. For use in economic evaluations, it 
is preferable that utility weights are available to compute a 
(care-related) quality of life score.
Concluding, this study in a multi-country sample of 
informal caregivers for people with dementia confirms pre-
vious findings in other populations that the CarerQol instru-
ment has satisfactory convergent and clinical validity in the 
population of informal caregivers for people with demen-
tia. These findings support that the CarerQol instrument is 
potentially useful in economic evaluation studies, either as 
additional information in evaluations of interventions for 
people with dementia or as a primary outcome measure in 
evaluations of interventions for informal caregivers.
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